{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:10:49Z","timestamp":1761235849513},"reference-count":31,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2019.4835","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T10:32:40Z","timestamp":1562063560000},"source":"Crossref","is-referenced-by-count":3,"title":["Suicide gene\u2011armed measles vaccine virus for the treatment of AML"],"prefix":"10.3892","author":[{"given":"Stefanie","family":"Maurer","sequence":"first","affiliation":[{"name":"Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Salih","sequence":"additional","affiliation":[{"name":"Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Smirnow","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine VIII, University Hospital Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Lauer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine VIII, University Hospital Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Berchtold","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine VIII, University Hospital Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"key20200713185919_b1-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/leu.2017.23","article-title":"Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure","volume":"31","author":"Wattad","year":"2017","journal-title":"Leukemia"},{"key":"key20200713185919_b2-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/sj.mt.6300108","article-title":"History of oncolytic viruses: Genesis to genetic engineering","volume":"15","author":"Kelly","year":"2007","journal-title":"Mol Ther"},{"key":"key20200713185919_b3-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1128\/JVI.02106-12","article-title":"Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis","volume":"87","author":"Berchtold","year":"2013","journal-title":"J Virol"},{"key":"key20200713185919_b4-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat Biotechnol"},{"key":"key20200713185919_b5-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrmicro1927","article-title":"Reprogrammed viruses as cancer therapeutics: Targeted, armed and shielded","volume":"6","author":"Cattaneo","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"key20200713185919_b6-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/v8100294","article-title":"Measles to the rescue: A rview of oncolytic measles virus","volume":"8","author":"Aref","year":"2016","journal-title":"Viruses"},{"key":"key20200713185919_b7-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.coi.2008.01.002","article-title":"MDA5\/RIG-I and virus recognition","volume":"20","author":"Takeuchi","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"key20200713185919_b8-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1126\/science.1132505","article-title":"5'-Triphosphate RNA is the ligand for RIG-I","volume":"314","author":"Hornung","year":"2006","journal-title":"Science"},{"key":"key20200713185919_b9-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"key20200713185919_b10-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.micinf.2006.04.005","article-title":"The interferon-inducible RNA helicase, mda-5, is involved in measles virus-induced expression of antiviral cytokines","volume":"8","author":"Bergh\u00e4ll","year":"2006","journal-title":"Microbes Infect"},{"key":"key20200713185919_b11-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.virol.2006.09.023","article-title":"mda-5, but not RIG-I, is a common target for paramyxovirus V proteins","volume":"359","author":"Childs","year":"2007","journal-title":"Virology"},{"key":"key20200713185919_b12-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.3748\/wjg.v11.i44.6910","article-title":"Bifunctional chimeric SuperCD suicide gene -YCD: YUPRT fusion is highly effective in a rat hepatoma model","volume":"11","author":"Graepler","year":"2005","journal-title":"World J Gastroenterol"},{"key":"key20200713185919_b13-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"e1008866","DOI":"10.1080\/2162402X.2015.1008866","article-title":"Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy","volume":"4","author":"Pol","year":"2015","journal-title":"OncoImmunology"},{"key":"key20200713185919_b14-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: Mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20200713185919_b15-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.canlet.2014.08.034","article-title":"Combination of vaccine-strain measles and mumps virus synergistically kills a wide range of human hematological cancer cells: Special focus on acute myeloid leukemia","volume":"354","author":"Zhang","year":"2014","journal-title":"Cancer Lett"},{"key":"key20200713185919_b16-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmak-ologischer Reihenversuche","volume":"162","author":"Kaerber","year":"1931","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"key20200713185919_b17-ijo-55-02-0347","first-page":"227","article-title":"The method of 'right and wrong cases' ('constant stimuli') without Gauss's formulae","volume":"2","author":"Spearman","year":"1908","journal-title":"Br J Psychol"},{"key":"key20200713185919_b18-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fmicb.2011.00247","article-title":"Measles virus hemagglutinin: Structural insights into cell entry and measles vaccine","volume":"2","author":"Hashiguchi","year":"2011","journal-title":"Front Microbiol"},{"key":"key20200713185919_b19-ijo-55-02-0347","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1128\/JVI.67.10.6025-6032.1993","article-title":"Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus","volume":"67","author":"Naniche","year":"1993","journal-title":"J Virol"},{"key":"key20200713185919_b20-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0092-8674(93)80071-L","article-title":"The human CD46 molecule is a receptor for measles virus (Edmonston strain)","volume":"75","author":"D\u00f6rig","year":"1993","journal-title":"Cell"},{"key":"key20200713185919_b21-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"1109e1110","DOI":"10.1016\/j.cell.2017.08.027","article-title":"Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy","volume":"170","author":"Ribas","year":"2017","journal-title":"Cell"},{"key":"key20200713185919_b22-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"14754","DOI":"10.1038\/ncomms14754","article-title":"Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun"},{"key":"key20200713185919_b23-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"e1412902","DOI":"10.1080\/2162402X.2017.1412902","article-title":"TNF\u03b1 and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade","volume":"7","author":"Cervera-Carrascon","year":"2018","journal-title":"OncoImmunology"},{"key":"key20200713185919_b24-ijo-55-02-0347","first-page":"39","article-title":"Chemovirotherapy: Combining chemotherapeutic treatment with oncolytic virotherapy","volume":"4","author":"Binz","year":"2015","journal-title":"Oncolytic Virother"},{"key":"key20200713185919_b25-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.omto.2017.04.001","article-title":"Chemovirotherapy of pancreatic adenocarcinoma by combining oncolytic vaccinia virus GLV-1h68 with nab-paclitaxel plus gemcitabine","volume":"6","author":"Binz","year":"2017","journal-title":"Mol Ther Oncolytics"},{"key":"key20200713185919_b26-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/cancers10060160","article-title":"A phase II study of pelareorep (REOLYSIN\u00ae) in combination with gemcitabine for patients with advanced pancreatic adenocarcinoma","volume":"10","author":"Mahalingam","year":"2018","journal-title":"Cancers (Basel)"},{"key":"key20200713185919_b27-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3892\/ijo.2013.1914","article-title":"Primary resistance phenomena to oncolytic measles vaccine viruses","volume":"43","author":"Noll","year":"2013","journal-title":"Int J Oncol"},{"key":"key20200713185919_b28-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"e1117740","DOI":"10.1080\/2162402X.2015.1117740","article-title":"Trial Watch-Oncolytic viruses and cancer therapy","volume":"5","author":"Pol","year":"2015","journal-title":"OncoImmunology"},{"key":"key20200713185919_b29-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/neuonc\/noy075","article-title":"Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC","volume":"20","author":"Cloughesy","year":"2018","journal-title":"Neuro-oncol"},{"key":"key20200713185919_b30-ijo-55-02-0347","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1182\/blood-2011-06-362442","article-title":"Unique dual targeting of thymidylate synthase and topoisomerase1 by FdUMP[10] results in high efficacy against AML and low toxicity","volume":"119","author":"Pardee","year":"2012","journal-title":"Blood"},{"issue":"Suppl 3","key":"key20200713185919_b31-ijo-55-02-0347","first-page":"1","article-title":"Suicide gene-armed measles vaccine virus for the treatment of AML. In: Proceedings of the Annual Meeting of the German Society for Haematology and Medical Oncology (DGHO) in Stuttgart","volume":"40","author":"der Deutschen","year":"2017","journal-title":"Oncol Res Treat"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:05:08Z","timestamp":1594667108000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2019.4835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":31,"URL":"https:\/\/doi.org\/10.3892\/ijo.2019.4835","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]}}}